Proteins associated with Cisplatin resistance in ovarian cancer cells identified by quantitative proteomic technology and integrated with mRNA expression levels.
about
P1343
Claudins overexpression in ovarian cancer: potential targets for Clostridium Perfringens Enterotoxin (CPE) based diagnosis and therapyMicroarray-assisted pathway analysis identifies MT1X & NFκB as mediators of TCRP1-associated resistance to cisplatin in oral squamous cell carcinomaQuantitative proteomic and interaction network analysis of cisplatin resistance in HeLa cellsResistance to paclitaxel in a cisplatin-resistant ovarian cancer cell line is mediated by P-glycoproteinSuppression of annexin A11 in ovarian cancer: implications in chemoresistance.Claudin-4 Expression is Associated With Survival in Ovarian Cancer But Not With Chemotherapy Response.WaveletQuant, an improved quantification software based on wavelet signal threshold de-noising for labeled quantitative proteomic analysisQuantitative proteomics of complex mixtures.Shotgun glycopeptide capture approach coupled with mass spectrometry for comprehensive glycoproteomics.Proteome response in HT-29 human colorectal cancer cells to two apoptosis-inducing compounds with different mode of action.Integrated analysis of DNA methylation and gene expression reveals specific signaling pathways associated with platinum resistance in ovarian cancerPathogenesis of ovarian cancer: clues from selected overexpressed genes.Analysis of chemotherapy response programs in ovarian cancers by the next-generation sequencing technologies.The MyD88+ phenotype is an adverse prognostic factor in epithelial ovarian cancer.Deep depletion of abundant serum proteins reveals low-abundant proteins as potential biomarkers for human ovarian cancer.Quantitative proteomic analysis by iTRAQ(R) for the identification of candidate biomarkers in ovarian cancer serum.Transcriptome interrogation of human myometrium identifies differentially expressed sense-antisense pairs of protein-coding and long non-coding RNA genes in spontaneous labor at term.Non-Biased Enrichment Does Not Improve Quantitative Proteomic Delineation of Reovirus T3D-Infected HeLa Cell Protein Alterations.Down-regulation of Ras-related protein Rab 5C-dependent endocytosis and glycolysis in cisplatin-resistant ovarian cancer cell lines.Claudins play a role in normal and tumor cell motilityClaudin 4 Is differentially expressed between ovarian cancer subtypes and plays a role in spheroid formation.A quantitative proteomics-based signature of platinum sensitivity in ovarian cancer cell lines.3-cinnamoyl-4-hydroxy-6-methyl-2H-pyran-2-one (CHP) inhibits human ovarian cell proliferation by inducing apoptosisClostridium perfringens enterotoxin (CPE) and CPE-binding domain (c-CPE) for the detection and treatment of gynecologic cancersClostridium perfringens enterotoxin C-terminal domain labeled to fluorescent dyes for in vivo visualization of micrometastatic chemotherapy-resistant ovarian cancerClaudin-4 overexpression in epithelial ovarian cancer is associated with hypomethylation and is a potential target for modulation of tight junction barrier function using a C-terminal fragment of Clostridium perfringens enterotoxin.Tangeretin sensitizes cisplatin-resistant human ovarian cancer cells through downregulation of phosphoinositide 3-kinase/Akt signaling pathway.Global tumor protein p53/p63 interactome: making a case for cisplatin chemoresistance.Claudin-4 activity in ovarian tumor cell apoptosis resistance and migrationUse of comparative proteomics to identify potential resistance mechanisms in cancer treatment.An integrative model for recurrence in ovarian cancer.Cancer proteomics by quantitative shotgun proteomics.Eradication of chemotherapy-resistant CD44+ human ovarian cancer stem cells in mice by intraperitoneal administration of Clostridium perfringens enterotoxinDrug resistance in cancer - searching for mechanisms, markers and therapeutic agents.Functional classification of cellular proteome profiles support the identification of drug resistance signatures in melanoma cells.Emerging roles of claudins in human cancerPlaying tag with quantitative proteomics.Metastasis of ovarian cancer is mediated by kallikrein related peptidases.Claudin and ovarian cancer.Cancer proteomics.
P2860
Q26851347-22096D98-D8B3-4B91-B6D1-8388F894BDD0Q28116304-7A1921C7-B143-4FFD-B7B9-9F501BEC6E0EQ28478299-C8348EF9-A25B-4578-AB5B-BE83B9688938Q28481246-DCC7A078-3D8F-402B-8FC6-87604F28655CQ30487754-8DF48450-6895-4ABC-9850-0209ADDC1AC7Q30491616-11BF55B1-B47F-4AF8-83F6-5B5CF95D267AQ30982085-A3630169-9413-4B9F-8848-6882EBA984CBQ31039257-840BC694-A3FE-4050-BB95-DD6302059160Q33262142-43EF08B1-AFD9-47D0-A786-2311F8C58C3FQ33316140-4D443729-DCB8-41B9-B387-F8F2056F2ACAQ33463860-022CDF64-A5D5-4725-9AB5-6F147B705095Q33651139-0917F5B9-3BF1-4694-8E68-65E494396F29Q33771027-C9DB7069-5090-414B-B7F5-F0DB405E2B4FQ33825555-20D8DF9D-9216-44B6-BECE-05D4A1A811E8Q33915813-D60ED461-6CEF-4218-A3A5-5A3BB0E64592Q33945104-CFA7D12C-4C20-4589-831B-AFBBAFAEE09CQ34400892-53C9071B-E8E9-46CF-9712-C2FD7D130BEEQ34424932-34D6E8C8-6A4C-46B8-8D2E-63CC8905859EQ34468400-5FCC27AC-E336-4F78-A12B-CB4452EEE603Q34632347-C5FE82D2-6500-4EDC-A4A4-ECF274960367Q34875061-7C98B47C-4235-4395-BA5F-5132763E5F03Q35031170-1D71530A-4466-4D45-9809-0E6B207081B9Q35145093-13693259-8103-496B-B1A3-D0668B427BA0Q35564030-360DC818-C020-4B42-9466-1ED8F399CA5DQ35659378-04775F5B-82DC-4BFD-B6D7-4832C103A8F3Q35756974-772845BC-6065-4553-850C-70C12CF6E279Q35869232-E1FBE6D0-F8D7-45A1-A7A6-8D9A241C04B0Q36059712-05A8CD8D-5334-44E7-A7EF-1D94C9403A6CQ36159864-E6FF82D5-3FFA-4A21-A30A-CBF9211B88E8Q36388185-570E89A1-AE2C-4AA9-B59D-E10A6EA76FFEQ36470173-86D5619D-F1F8-4212-AC15-464A572DA528Q36600420-23BABC55-EA2C-4C24-B919-3369B080D103Q36983929-682A7F5E-EEBE-4E08-A420-F306F20A3116Q37008882-72FA85E3-D7BB-4375-88E0-9A6D053AA6DFQ37069163-546A8973-21C3-460B-99B4-34C34B351D9FQ37225107-E54C8889-36B7-4043-AC1D-8D3AF0FCDCE7Q37289854-9389C5E4-BB0B-4FDF-A6A9-6E5A2B1A72FAQ37480184-A6D816B9-03F9-46FF-A5E9-2C9745CF386AQ37611453-2957D7B4-EDE6-4DA7-8A3B-F15D5585491FQ37994133-10179A61-D27B-424C-8E65-9C96B74B5F81
P2860
Proteins associated with Cisplatin resistance in ovarian cancer cells identified by quantitative proteomic technology and integrated with mRNA expression levels.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Proteins associated with Cispl ...... d with mRNA expression levels.
@en
Proteins associated with Cispl ...... d with mRNA expression levels.
@nl
type
label
Proteins associated with Cispl ...... d with mRNA expression levels.
@en
Proteins associated with Cispl ...... d with mRNA expression levels.
@nl
prefLabel
Proteins associated with Cispl ...... d with mRNA expression levels.
@en
Proteins associated with Cispl ...... d with mRNA expression levels.
@nl
P2093
P2860
P1476
Proteins associated with Cispl ...... d with mRNA expression levels.
@en
P2093
Biaoyang Lin
Charles W Drescher
James T White
Jennifer J Stewart
Nicole D Urban
Steven Collins
Xiaowei Yan
P2860
P304
P356
10.1074/MCP.M500140-MCP200
P4510
P50
P577
2005-11-30T00:00:00Z